TZIELD 1 mg/mL
teplizumab-mzwv · INJECTION · Provention Bio, Inc.
No Recall History
Plain English
TZIELD is a injection containing teplizumab-mzwv at 1 mg/mL, taken intravenous. Manufactured by Provention Bio, Inc..
Key Facts
- Brand Name
- TZIELD
- Generic Name
- teplizumab-mzwv
- NDC Code (Product)
73650-316- Manufacturer
- Provention Bio, Inc.
- Strength
- 1 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761183
- Drug Class
- CD3-directed Antibody [EPC]
- Marketing Start
- 11/17/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is TZIELD used for?
TZIELD contains teplizumab-mzwv. It is a injection taken intravenous. Consult your doctor for specific uses.
Is TZIELD a controlled substance?
TZIELD is not classified as a controlled substance by the DEA.
What is the generic name for TZIELD?
The generic name for TZIELD is teplizumab-mzwv. There are no other listed brand versions of teplizumab-mzwv.
What is the NDC code for TZIELD 1 mg/mL?
The NDC (National Drug Code) for TZIELD 1 mg/mL is 73650-316, listed by Provention Bio, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)